SOLINADE Trademark

Trademark Overview

On Tuesday, November 4, 2014, a trademark application was filed for SOLINADE with the United States Patent and Trademark Office. The USPTO has given the SOLINADE trademark a serial number of 86444118. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 7, 2018. This trademark is owned by Alkermes Pharma Ireland Limited. The SOLINADE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and compounds, namely, small molecules and chemical compounds for use in opioid modulation; Pharmaceutical preparations and compounds for use in treating CNS disorders
solinade

General Information

Serial Number86444118
Word MarkSOLINADE
Filing DateTuesday, November 4, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 7, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 3, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations and compounds, namely, small molecules and chemical compounds for use in opioid modulation; Pharmaceutical preparations and compounds for use in treating CNS disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 14, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAlkermes Pharma Ireland Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDublin 4
IE
Party NameAlkermes Pharma Ireland Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDublin 4
IE

Trademark Events

Event DateEvent Description
Monday, May 7, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 7, 2018ABANDONMENT - NO USE STATEMENT FILED
Wednesday, September 6, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Tuesday, September 5, 2017EXTENSION 5 GRANTED
Friday, September 1, 2017EXTENSION 5 FILED
Friday, September 1, 2017TEAS EXTENSION RECEIVED
Thursday, February 9, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Tuesday, February 7, 2017EXTENSION 4 GRANTED
Tuesday, February 7, 2017EXTENSION 4 FILED
Tuesday, February 7, 2017TEAS EXTENSION RECEIVED
Friday, August 5, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Thursday, August 4, 2016EXTENSION 3 GRANTED
Monday, August 1, 2016EXTENSION 3 FILED
Monday, August 1, 2016TEAS EXTENSION RECEIVED
Friday, February 19, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Thursday, February 18, 2016EXTENSION 2 GRANTED
Monday, February 8, 2016EXTENSION 2 FILED
Monday, February 8, 2016TEAS EXTENSION RECEIVED
Wednesday, September 16, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Tuesday, September 15, 2015EXTENSION 1 GRANTED
Tuesday, September 1, 2015EXTENSION 1 FILED
Monday, September 14, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 1, 2015TEAS EXTENSION RECEIVED
Tuesday, March 31, 2015NOA MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, February 4, 2015NOTICE OF PUBLICATION
Tuesday, February 3, 2015PUBLISHED FOR OPPOSITION
Wednesday, January 28, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 28, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 14, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, December 22, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, December 20, 2014ASSIGNED TO EXAMINER
Friday, November 14, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, November 7, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

solinade compounds preparations pharmaceutical modulation disorders opioid treating molecules namely small